Skip to main content

Table 5 Secondary outcomes at 30 days after surgery

From: Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks

  All patients Mechanical valve No mechanical valve
N = 411 N = 257 N = 154
Secondary outcomes - no. (%)
Clinically significant hematoma 24 5.8% 18 7.0% 6 3.9%
 Hematoma prolonging hospitalization 24 5.8% 18 7.0% 6 3.9%
 Hematoma requiring additional interruption of anti-coagulation 15 3.7% 9 3.5% 6 3.9%
 Hematoma requiring evacuation 6 1.5% 4 1.6% 2 1.3%
Pneumothorax 0 0.0% 0 0.0% 0 0.0%
Hemothorax 0 0.0% 0 0.0% 0 0.0%
Cardiac tamponade 0 0.0% 0 0.0% 0 0.0%
Lead dislodgement 4 1.0% 3 1.2% 1 0.7%
Infection related to device system 4 1.0% 3 1.2% 1 0.7%
Myocardial infarction 0 0.0% 0 0.0% 0 0.0%
Major bleeding unrelated to CIED 2 0.5% 2 0.8% 0 0.0%
  1. Abbreviation: CIED cardiac implantable electronic device